{"id":2206,"date":"2025-09-22T15:34:47","date_gmt":"2025-09-22T15:34:47","guid":{"rendered":"http:\/\/www.globaltalenthq.com\/?p=2206"},"modified":"2025-09-22T18:37:08","modified_gmt":"2025-09-22T18:37:08","slug":"trump-team-poised-to-link-popular-meds-with-autism-risk-wapo","status":"publish","type":"post","link":"http:\/\/www.globaltalenthq.com\/index.php\/2025\/09\/22\/trump-team-poised-to-link-popular-meds-with-autism-risk-wapo\/","title":{"rendered":"Trump team poised to link popular meds with autism risk \u2013 WaPo"},"content":{"rendered":"
The White House is also expected to promote a new drug as a possible treatment for the condition, the outlet has said<\/strong><\/p>\n<\/p>\n The administration of US President Donald Trump plans on Monday to announce a possible link between Tylenol use in pregnancy and autism risk in children, The Washington Post has reported citing several officials familiar with the plan. <\/p>\n Studies by Mount Sinai and Harvard researchers, published in August, suggested a possible association between acetaminophen – the active ingredient in Tylenol and one of the most widely used medications worldwide – taken early in pregnancy and autism, the outlet said on Monday. The administration will reportedly advise women to avoid Tylenol unless they need it to fight a fever.<\/p>\n At the same time, the White House is expected to promote leucovorin, a drug normally used for vitamin B9 deficiency, as a potential treatment for autism. According to some scientists, early trials showed “remarkable improvements”<\/em> in speech and understanding among children with autism, prompting the Food and Drug Administration (FDA) review and renewed debate over the condition’s causes.<\/p>\n Trump previewed the announcement in a speech on Sunday, saying: “Tomorrow we’re going to have one of the biggest announcements medically, I think, in the history of our country. I think you’re going to find it to be amazing. I think we found an answer to autism.”<\/em><\/p>\n